1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Opportunities is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). NIH SBIR/STTR grant funding opportunities offer small business entrepreneurs non-dilutive funding for early-stage biomedical and behavioral research and development. Applications are accepted three times a year.
Get alerted about grants like this
Save a search for “National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC)” or related topics and get emailed when new opportunities appear.
Search similar grants →Based on current listing details, eligibility includes: Small business concerns that possess the research and development (R&D) expertise to conduct innovative research that will contribute toward NIH or CDC mission needs. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Not specified, varies by opportunity Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is September 5, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Past winners and funding trends for this program
PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) (Clinical Trial Required) is sponsored by National Cancer Institute (NCI) of the National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). This omnibus solicitation is for SBIR grant applications from small business concerns focusing on the commercial development of novel cancer-relevant technologies that require a clinical trial.
PHS 2023 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). The NIH SBIR/STTR program is a congressionally mandated set-aside for U.S. small businesses to engage in research and development activities with strong potential for commercialization, particularly in life sciences and health-related technologies. This Omnibus solicitation provides an overarching opportunity for researcher-initiated ideas.
Small Business Innovation Research (SBIR) / Small Business Technology Transfer (STTR) is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). The NIH and CDC SBIR/STTR programs solicit proposals from small business concerns with R&D expertise to conduct innovative research contributing to NIH or CDC mission needs. These programs aim to stimulate technological innovation, strengthen the role of small business in meeting Federal R&D needs, encourage participation by socially and economically disadvantaged small businesses, and increase private sector commercialization of innovations.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.
This initiative will stimulate and support innovative research by small business concerns that may lead to the development of novel technologies for the early diagnosis, monitoring and treatment of micro and macro vascular complications of diabetes which are associated with significant morbidity and mortality of the disease and high costs to the health care system. Funding Opportunity Number: PA-14-058. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL.